Trial · NCT01260688
Trial comparisons11
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 11 of 11
Download this page as JSON| Comparison | Source |
|---|---|
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: Treatment Related Deaths | Trial comparisons |
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: Treatment Discontinuation Due to Adverse Events (AEs) | Trial comparisons |
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: Dose Reductions | Trial comparisons |
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: 12-week Progression-free Survival as Per the Prostate Cancer Clinical Trials Working Group (PCWG2) | Trial comparisons |
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: Dose Interruption Due to AEs | Trial comparisons |
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: Qualtiy of Life Assessment Number of Participants With a Score ≥2 on the Present Pain Intensity (PPI) Scale | Trial comparisons |
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: Participants for Which Bone Biomarkers for Beta-C Telopeptide Was Reduced | Trial comparisons |
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: Treatment Discontinuation | Trial comparisons |
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: Number of Participants With Toxicities | Trial comparisons |
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: Number of Participants With Increased Alkaline Phosphatase BAP | Trial comparisons |
| Arm I - Cediranib Plus Dasatinib vs Arm II - Cediranib Alone: serious adverse events | Trial comparisons |
trials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01260688/comparisons